PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Pelthos Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$20.26+0.11 (+0.55%)
Close on Oct 19, 2026
- Market cap
- $71.71M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Pelthos Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 29, 2026 | Oct 1, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 29, 2026 | Aug 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 21, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2025 | Jan 2, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2025 | Dec 23, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 17, 2025 | Dec 17, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 17, 2025 | Nov 25, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 3, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2025 | Jul 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 17, 2025 | Apr 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 21, 2024 | Nov 21, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2024 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2024 | Oct 24, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 22, 2024 | Sep 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 7, 2024 | SEC EDGAR |